Sponsor:
University of Pennsylvania
Code:
NCT07444203
Conditions
Diabetic Nephropathies
Kidney Diseases
Renal Insufficiency, Chronic
Diabetes Mellitus, Type 2
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
Sodium-glucose cotransporter 2 inhibitors (SGLT2i)
Renin-angiotensin-aldosterone system blockade
Glucagon-like peptide-1 receptor agonists (GLP 1 RA)
Mineralocorticoid Receptor Antagonists(MRAs)
Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-26. This information was provided to ClinicalTrials.gov by University of Pennsylvania on 2026-03-02.